Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04863157 · ClinicalTrials.gov registry record · NA

Survivor-Sleep Health Information Program

A NA study, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT04863157 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 16 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04863157, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

The purpose of the study is to learn if an educational program delivered to parents/guardians can help improve the sleep of children experiencing sleep problems after completing cancer treatment. The name of the intervention is Survivor-SHIP (Sleep Health Information Program).

Interventions

  • BEHAVIORAL Survivor-SHIP

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2021-05-24
Est. Completion 2022-12-31
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT04863157

The ClinicalTrials.gov registry entry for NCT04863157 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Survivor-SHIP is the first listed.

NCT04863157 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04863157 about?

NCT04863157 is a clinical study titled "Survivor-Sleep Health Information Program". The purpose of the study is to learn if an educational program delivered to parents/guardians can help improve the sleep of children experiencing sleep problems after completing cancer treatment. The name of the intervention is Survivor-SHIP (Sleep Health Information Program).

What is the current status of trial NCT04863157?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-05-24. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT04863157?

The interventions under investigation include: Survivor-SHIP (BEHAVIORAL).

Who is sponsoring clinical trial NCT04863157?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.